More Globe Newswire

View Older Stories View Newer Stories

Feb 16, 2024 02:00AM Stockwik publishes year-end report January 1st - December 31st, 2023
Feb 16, 2024 02:00AM Nexans launches a share buyback program
Feb 16, 2024 02:00AM QPR Software Plc’s Financial Statements Bulletin: January–December 2023
Feb 16, 2024 02:00AM Smart Immune appoints key new members to its Board of Directors
Feb 16, 2024 02:00AM ING to redeem Perpetual Capital Securities
Feb 16, 2024 02:00AM Year-end Report - January-December 2023
Feb 16, 2024 01:45AM Form 8.5 (EPT/RI) - Abrdn European Logistics Income Plc
Feb 16, 2024 01:45AM Form 8.5 (EPT/RI) = Kin and Carta Plc
Feb 16, 2024 01:45AM Vistin Pharma ASA: Fourth quarter and preliminary 2023 financial results
Feb 16, 2024 01:45AM Edf: 2023 Annual Results: Substantially higher nuclear power output in France - Good overall operational performance - New commercial policy - Net financial debt reduced - Trajectory 1.5°C validated
Feb 16, 2024 01:45AM Inside information: Aspocomp has completed its change negotiations in Finland
Feb 16, 2024 01:37AM
Feb 16, 2024 01:30AM Umicore: FULL YEAR RESULTS 2023
Feb 16, 2024 01:30AM Transaction in Own Shares
Feb 16, 2024 01:30AM BGHL (GBP): NAV(s)
Feb 16, 2024 01:30AM BGHL (GBP): NAV(s)
Feb 16, 2024 01:30AM BGHL (EUR): NAV(s)
Feb 16, 2024 01:00AM Start of Day Message
Feb 16, 2024 01:00AM Press Release: Japan first in the world to approve Dupixent® for chronic spontaneous urticaria (CSU)
Feb 16, 2024 01:00AM Aspo Group financial statement release, January 1 – December 31, 2023
Feb 16, 2024 01:00AM AS Ekspress Grupp: Consolidated unaudited interim report for Q4 and 12 months of 2023
Feb 16, 2024 12:59AM Japan First in the World to Approve Dupixent® (dupilumab) for Chronic Spontaneous Urticaria (CSU)
Feb 16, 2024 12:59AM Japan First in the World to Approve Dupixent® (dupilumab) for Chronic Spontaneous Urticaria (CSU)
Feb 16, 2024 12:36AM B2Gold Reports Three Fatalities from Off-Site Incident in Mali
Feb 15, 2024 11:30PM MERCURY SYSTEMS ALERT: Bragar Eagel & Squire, P.C. is Investigating Mercury Systems, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Feb 15, 2024 11:30PM WELLS FARGO ALERT: Bragar Eagel & Squire, P.C. is Investigating Wells Fargo & Company on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Feb 15, 2024 11:30PM NUSCALE ALERT: Bragar Eagel & Squire, P.C. is Investigating NuScale Power Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Feb 15, 2024 11:30PM TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Talis Biomedical Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Feb 15, 2024 11:30PM TASKUS ALERT: Bragar Eagel & Squire, P.C. is Investigating TaskUs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Feb 15, 2024 11:30PM VIRGIN GALACTIC ALERT: Bragar Eagel & Squire, P.C. is Investigating Virgin Galactic Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Feb 15, 2024 11:30PM BRIGHT HEALTH ALERT: Bragar Eagel & Squire, P.C. is Investigating Bright Health Group, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Feb 15, 2024 11:30PM BLOCK ALERT: Bragar Eagel & Squire, P.C. is Investigating Block, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Feb 15, 2024 11:30PM ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Feb 15, 2024 11:30PM FRESHWORKS ALERT: Bragar Eagel & Squire, P.C. is Investigating Freshworks Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Feb 15, 2024 11:30PM MICROVAST ALERT: Bragar Eagel & Squire, P.C. is Investigating Microvast Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Feb 15, 2024 11:30PM CHEMOURS ALERT: Bragar Eagel & Squire, P.C. is Investigating The Chemours Company on Behalf of Chemours Stockholders and Encourages Investors to Contact the Firm
Feb 15, 2024 11:00PM RECORD RESULTS FOR SALES, CASH FLOW, AND ADJUSTED EBIT
Feb 15, 2024 09:24PM Flash News: OKX Launches New P2P Campaign with USD100,000 Reward Pool
Feb 15, 2024 09:00PM Flash News: OKX Wallet Web Extension Users Can Now Enjoy Seamless Access to TiTiTi, an NFT Research Lab
Feb 15, 2024 09:00PM AMPLITUDE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Amplitude, Inc. and Encourages Investors to Contact the Firm
Feb 15, 2024 09:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against iRhythm, Hut 8, and Xponential and Encourages Investors to Contact the Firm
Feb 15, 2024 08:58PM Pulse Seismic Inc. Reports 2023 Financial Results and Declares Dividend
Feb 15, 2024 08:25PM Rubicon Organics Announces the Appointment of Chief Executive Officer and Chief Financial Officer, and Grants RSUs
Feb 15, 2024 08:00PM EnWave to Report First Quarter Financial Results on February 22, 2024 and Host Investor Conference Call
Feb 15, 2024 07:01PM C.K. McWhorter & Family Request Immediate Federal Protection Amidst Rising Extortion Threats, Coercion and Systemic Harassment
Feb 15, 2024 07:01PM C.K. McWhorter & Family Request Immediate Federal Protection Amidst Rising Extortion Threats, Coercion and Systemic Harassment
Feb 15, 2024 07:01PM Interfor Announces Lumber Production Curtailments in Oregon and British Columbia
Feb 15, 2024 06:52PM Peyto Delivers Strong Reserves Growth In 2023
Feb 15, 2024 06:36PM DMG Blockchain Solutions Announces Relationship with Sygnum Bank to Provide Credit Facility
Feb 15, 2024 06:35PM Sosei Group: Notice of Change of Corporate Name to Nxera Pharma and Change of Location of Head Office
View Newer Stories View Older Stories